Objective
DMO, peripheral retinal ischaemia
DIABETIC MACULAR OEDEMA
We tested the hypothesis that targeted retinal laser photocoagulation (TPRP) to peripheral retinal ischaemia reduces the overall burden of aflibercept injections when treating diabetic macular oedema (DMO) over a 24-month period.